Pricing Log in Create free account

Cumberland Pharmaceuticals Inc. (CPIX) vs Organogenesis (ORGO)

Cumberland Pharmaceuticals Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $142.8M against $113.0M — 1.3× the size. Cumberland Pharmaceuticals Inc. grew revenue faster over the last twelve months: 32.0% against 6.50%. Organogenesis has the higher net margin (−22.2% vs −26.2%) and the higher return on invested capital (−20.0% vs −34.2%). Across the 20 metrics below, Organogenesis leads on 13 and Cumberland Pharmaceuticals Inc. on 7.

Valuation

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.58 0.28 2.11
P/B 6.29 0.86 1.78
Price to free cash flow 186.79 6.11 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 2.73 0.21 2.73
Earnings yield (9.89%) (85.86%) (4.38%)
Free cash flow yield 0.54% 16.36% 0.00%

Profitability

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
Gross margin 82.80% 70.35% 53.94%
Operating margin (17.39%) (7.84%) 0.00%
Net margin (26.17%) (22.23%) 0.00%
Free cash flow margin 1.38% 4.56% 0.00%
Return on equity (48.76%) (53.31%) (0.40%)
Return on assets (16.70%) (23.44%) (3.32%)
Return on invested capital (34.23%) (19.97%) 0.00%

Growth

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 31.98% 6.50% 10.01%
EPS growth (last fiscal year) 58.70% 1,600.00% 49.06%
Revenue growth, 5-year CAGR 3.52% 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.07 0.05
Current ratio 0.96 3.52 2.31
Net debt to EBITDA (4.58) (1.14) 0.97

Dividend

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.57%
Payout ratio — — 0.27

Size

Metric CPIX ORGO Drug Manufacturers Specialty & Generic median
Market cap 112.97m 142.83m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack